Unigen, Inc, 3005 1st Ave, Seattle, WA, 98121, USA.
Diabetol Metab Syndr. 2014 May 24;6:61. doi: 10.1186/1758-5996-6-61. eCollection 2014.
There are a few nutritional approaches to address the increased needs of managing diabetic conditions. Previously it has been reported that UP780, a standardized composition of aloe chromone formulated with an aloe polysaccharide, has a significant impact in reducing HbA1C, fasting blood glucose, fructosamine and plasma insulin level in humans and improved impaired glucose and insulin resistance in high-fat diet-induced and db/db non-insulin dependent diabetic mouse models. Here we describe activity of UP780 and its constituents to improve insulin sensitivity in alloxan induced insulin dependent diabetic mouse model.
Insulin dependent diabetes was induced by administering a single intraperitoneal injection of alloxan monohydrate at a dose of 150 mg/kg to CD-1 mice. Aloesin (UP394) was formulated with an Aloe vera inner leaf gel powder polysaccharide (Qmatrix) to yield a composition designated UP780. Efficacy of oral administration of UP780 at 2000 mg/kg and its constituents (aloesin at 80 mg/kg and Qmatrix at 1920 mg/kg) were evaluated in this model. Glyburide, a sulfonylurea drug used in the treatment of type 2 diabetes, was used at 5 mg/kg as a positive control. Effect of UP780 on non-diabetic normal mice was also addressed.
Mice administered intraperitoneal alloxan monohydrate developed progressive type-1 diabetes like symptom. After 4 weeks of daily oral administration, reductions of 35.9%, 17.2% and 11.6% in fasting blood glucose levels were observed for UP780, the UP780 Aloe vera inner leaf gel polysaccharide preparation without chromone (Qmatrix), and Aloesin (UP394), treated animals respectively, compared to vehicle treated animals. UP780 has no impact on blood glucose level of non-diabetic healthy mice. UP780 showed statistically significant improvement for blood glucose clearance in oral glucose tolerance tests. Similarly, enhanced improvement in plasma insulin level and statistically significant reduction in triglyceride level was also observed for animals treated with the composition.
These findings suggest that UP780, a chromone standardized Aloe based composition, could possibly be used as a natural supplement alternative to facilitate maintenance of healthy blood glucose levels.
有几种营养方法可以满足管理糖尿病的更高需求。以前有报道称,UP780 是一种由标准化的芦荟色酮组成的配方,与芦荟多糖结合使用,可显著降低人类的 HbA1C、空腹血糖、果糖胺和血浆胰岛素水平,并改善高脂肪饮食诱导的葡萄糖和胰岛素抵抗受损和 db/db 非胰岛素依赖型糖尿病小鼠模型。在这里,我们描述了 UP780 及其成分在改善链脲佐菌素诱导的胰岛素依赖型糖尿病小鼠模型中胰岛素敏感性的作用。
通过向 CD-1 小鼠单次腹腔注射 150mg/kg 一水合链脲佐菌素诱导胰岛素依赖型糖尿病。芦荟色酮(UP394)与芦荟内叶凝胶粉多糖(Qmatrix)配制成指定为 UP780 的组合物。在该模型中评估了 UP780 口服 2000mg/kg 及其成分(80mg/kg 的芦荟色酮和 1920mg/kg 的 Qmatrix)的疗效。使用磺酰脲类药物格列本脲(用于治疗 2 型糖尿病的药物)作为阳性对照,剂量为 5mg/kg。还研究了 UP780 对非糖尿病正常小鼠的影响。
腹腔注射一水合链脲佐菌素的小鼠逐渐出现 1 型糖尿病样症状。经过 4 周的每日口服给药,与 vehicle 处理的动物相比,UP780、不含色酮的 UP780 芦荟内叶凝胶多糖制剂(Qmatrix)和芦荟色酮(UP394)处理的动物的空腹血糖水平分别降低了 35.9%、17.2%和 11.6%。UP780 对非糖尿病健康小鼠的血糖水平没有影响。UP780 在口服葡萄糖耐量试验中显示出血糖清除的统计学显著改善。同样,对动物的治疗也观察到血浆胰岛素水平的提高和甘油三酯水平的统计学显著降低。
这些发现表明,UP780 是一种标准化的色酮芦荟基组合物,可作为天然补充剂的替代物,有助于维持健康的血糖水平。